Skip to content
Simpler Grants

No. HT942526BMFRPIDA · Defense Health Agency Contracting Activity - DHACA

Open

DoW Bone Marrow Failure, Idea Development Award

grants.gov listing Full announcement (NOFO)
Dealbreakers No cost share required Audit: not stated Reimbursement-only: not stated
Award range
Not specified
Expected awards
~5
Application deadline
Nov 4, 2026
Posted
Jun 17, 2026
Last verified
3 days ago

At a glance

AI summary

The Bone Marrow Failure Research Program Idea Development Award funds innovative, high-impact research on inherited or acquired bone marrow failure diseases, including studies on causes, progression, treatment, and some correlative studies tied to clinical trials or clinical samples. It is open to eligible U.S. Department of War organizations and independent investigators at eligible organizations, including nonprofit and for-profit, domestic and foreign entities; applicants may apply as Established Investigators or Early-Career Investigators. The program expects about $4.0 million to support about five awards, with a total cost cap of $800,000 per award and a maximum project period of 3 years. Cost sharing is not required. The announcement does not limit applicants by geography beyond the eligible organization rules, but it excludes applications with a primary focus on myeloproliferative neoplasms, leukemia, or other malignancies, and it does not allow clinical trials.

AI-generated summary — verify against the announcement

What it funds

  • Science and Technology and other Research and Development
  • Research & Discovery
  • Researchers & Scholars
  • Biomedical & Disease Research
Official description from grants.gov

Summary: The BMFRP Idea Development Award (IDA) is intended to support innovative ideas and high-impact approaches based on scientifically sound evidence to move toward the BMFRP’s vision of understanding and curing BMF diseases. Distinctive Features: This funding opportunity is open to Established Investigators (EIs) and Early-Career Investigators (ECIs). Reviewers will assess Principal Investigators (PIs) using distinct review criteria based on their eligibility as an EI or ECI. Preliminary data is not required. Applications should demonstrate the ability to achieve interpretable results in the absence of preliminary data supporting the hypothesis.

Who can apply

  • Unrestricted
Geographic restriction None found in the announcement — likely nationwide

Program history

USASpending.gov

Assistance listing 12.420 · Military Medical Research and Development

Real awards this federal program has made — the whole assistance listing (12.420), not just this notice.

Fiscal year Awards Median award Middle half
FY 2026 (so far) 374 $934,195 $559,998 – $1,477,811
FY 2025 967 $796,174 $416,995 – $1,480,602
FY 2024 1,097 — —
FY 2023 1,115 — —
FY 2022 1,186 — —
FY 2021 1,023 — —

Dollar figures are based on the 1,000 most recent awards we store, not all 5,762 — award counts are complete.

Who wins it Business (127), Nonprofit (34), Higher education (2) of 5,762 awards — categories can overlap.
Top states CA (135) · TX (103) · NY (99) · MA (74) · MD (38)
Largest recent awards
  1. THE UNIVERISTY OF TEXAS M.D. ANDERSON CANCER CENTER $19,100,256 · FY 2025
  2. H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE HOSPITAL, INC. $18,696,738 · FY 2025
  3. UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE $10,606,583 · FY 2025
  4. SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH $10,500,000 · FY 2026
  5. UNIVERSITY OF VERMONT & STATE AGRICULTURAL COLLEGE $8,491,997 · FY 2025

Source: USASpending.gov · refreshed Aug 25, 2026